Topics:
Head and Neck Cancers • Medical Oncology • NCI-CCC Tumor Board Question • Indiana University
In light of recent data from ASCO 2019 and the NEJM, would you recommend induction chemotherapy or an adjuvant approach in combination with chemoradiation for locally advanced nasopharyngeal carcinoma?
Does your approach differ by EBV status?
Answer from: Medical Oncologist at Community Practice
Definitely, and yes mainly for EBV positive tumors.That trial certainly provides not only rationale for using induction Cis-Gemcitabine, but also the little role left of adjuvant therapy.
Sign in or Register to read more